Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov ID: NCT04630808

Public ClinicalTrials.gov record NCT04630808. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 3:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Multi-Regional, Double-Masked, Parallel-Group Trial Evaluating the Safety and Efficacy of NCX 470 0.1% vs. Latanoprost 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this clinical study is to evaluate the safety and efficacy of NCX 470 Ophthalmic Solution in lowering intraocular pressure (IOP) in subjecs with ocular hypertension or open-angle glaucoma. Subjects will be randomized in a 1:1 ratio to NCX 470 0.1% or to latanoprost 0.005% to be administered to both eyes once daily in the evening for up to 12 months.

Study identification

NCT ID
NCT04630808
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Nicox Ophthalmics, Inc.
Industry
Enrollment
696 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 84 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 8, 2020
Primary completion
Apr 10, 2025
Completion
Jun 24, 2025
Last update posted
Sep 7, 2025

2020 – 2025

United States locations

U.S. sites
63
U.S. states
24
U.S. cities
57
Facility City State ZIP Site status
Nicox Clinical Site Dothan Alabama 36301
Nicox Clinical Site Chandler Arizona 85224
Nicox Clinical Site Phoenix Arizona 85003
Nicox Clinical Site Burbank California 91505
Nicox Clinical Site Garden Grove California 92843
Nicox Clinical Site Huntington Beach California 92647
Nicox Clinical Site La Jolla California 92037
Nicox Clinical Site Murrieta California 92562
Nicox Clinical Site Newport Beach California 92663
Nicox Clinical Site Pasadena California 91107
Nicox Clinical Site Petaluma California 94954
Nicox Clinical Site Redlands California 92373
Nicox Clinical Site San Francisco California 94115
Nicox Clinical Site Danbury Connecticut 06810
Nicox Clinical Site Boynton Beach Florida 33437
Nicox Clinical Site Delray Beach Florida 33484
Nicox Clinical Site Fort Lauderdale Florida 33309
Nicox Clinical Site Fort Myers Florida 33901
Nicox Clinical Site Jacksonville Florida 32256
Nicox Clinical Site Jupiter Florida 33477
Nicox Clinical Site Lakeland Florida 33805
Nicox Clinical Site Largo Florida 33770
Nicox Clinical Site Mt. Dora Florida 32757
Nicox Clinical Site Venice Florida 34285
Nicox Clinical Site Morrow Georgia 30260
Nicox Clinical Site Roswell Georgia 30076
Nicox Clinical Site Peoria Illinois 61615
Nicox Clinical Site Rock Island Illinois 61201
Nicox Clinical Site Indianapolis Indiana 46202
Nicox Clinical Site Bangor Maine 04401
Nicox Clinical Site Boston Massachusetts 02114
Nicox Clinical Site Lancaster Massachusetts 01523
Nicox Clinical Site Grand Rapids Michigan 49546
Nicox Clinical Site Chaska Minnesota 55318
Nicox Clinical Site Kansas City Missouri 64111
Nicox Clinical Site St Louis Missouri 63128
Nicox Clinical Site Clifton Park New York 12065
Nicox Clinical Site The Bronx New York 10467
Nicox Clinical Site Troy New York 12180
Nicox Clinical Site Asheville North Carolina 28803
Nicox Clinical Site Winston-Salem North Carolina 27101
Nicox Clinical Site Fargo North Dakota 58103
Nicox Clinical Site Cincinnati Ohio 45236
Nicox Clinical Site Cincinnati Ohio 45242
Nicox Clinical Site Eugene Oregon 97401
Nicox Clinical Site Cranberry Township Pennsylvania 16066
Nicox Clinical Site Kingston Pennsylvania 18704
Nicox Clinical Site Memphis Tennessee 38119
Nicox Clinical Site Memphis Tennessee 38120
Nicox Clinical Site Austin Texas 78731
Nicox Clinical Site El Paso Texas 79922
Nicox Clinical Site Houston Texas 77008
Nicox Clinical Site Houston Texas 77025
Nicox Clinical Site Mission Texas 78572
Nicox Clinical Site San Antonio Texas 78212
Nicox Clinical Site San Antonio Texas 78229
Nicox Clinical Site San Antonio Texas 78238
Nicox Clinical Site Sugar Land Texas 77479
Nicox Clinical Site St. George Utah 84790
Nicox Clinical Site Falls Church Virginia 22042
Nicox Clinical Site Bellevue Washington 98004
Nicox Clinical Site Seattle Washington 98104
Nicox Clinical Site Seattle Washington 98125

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04630808, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 7, 2025 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04630808 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →